Last chance! Our lowest rates end at 10PM Pacific on 4/30! (April 29, 2019) Don’t miss your chance to register at our discount rate of only $185. Ovarian cancer survivors, caregivers, supporters and experts travel from all over the country for OCRA’s Ovarian Cancer National Conference – an educational weekend of friendship, information, and hope. … Continued
(April 3, 2019) In March, ovarian cancer researchers, clinicians and advocates gathered to attend the much-anticipated Society of Gynecologic Oncology’s (SGO) 50th Annual Meeting on Women’s Cancer, to discuss the latest cutting edge research. OCRA Research Advocate, Scientific Advisory Committee member, and ovarian cancer survivor Annie Ellis attended the meeting and wrote a report highlighting … Continued
(April 3, 2019) We have one week to let the Senate know that we need more funding for ovarian cancer research! Thanks to your efforts, a record 158 U.S. House members signed a Dear Colleague letter calling for more funding for the Ovarian Cancer Research Program (OCRP) at the Department of Defense. Now we need … Continued
Join us Monday, May 20, 2019 at Carolines on Broadway in NYC for an evening of laughter, plus cocktails, hors d’oeuvre and a live auction, all to end ovarian cancer. Featuring laugh-out-loud performances from comedic favorites Mike Birbiglia, Ronny Chieng and Robert Klein, with more to be announced! Proceeds benefit OCRA’s ovarian cancer research and support programs … Continued
(April 1, 2019) 156 House Members have joined Reps. DeLauro and Duffy in a call for increased ovarian cancer research funding. Reps. Rosa DeLauro (D-CT) and Sean Duffy (R-WI) – co-chairs of the Congressional Ovarian Cancer Caucus – today delivered a “Dear Colleague” letter to the House Defense Appropriations Subcommittee requesting a $15 million increase in … Continued
Empower yourself with the latest research updates at OCRA’s National Conference. Register today. It can be overwhelming trying to keep up with what’s new in the ovarian cancer field, and how new discoveries may affect you. At OCRA’s National Conference, you can get a front row seat at expert plenary and breakout sessions, where leaders … Continued
OCRA is now on Shopify and Poshmark Wardrobe need a refresh? Now you can shop high-end, limited quantity designer goods online at deep discounts, all while supporting the fight against ovarian cancer. Browse our exciting collection of shoes, accessories, and apparel for women, men and children, from top brands including Johnny Was, Ramy Brook, Kenneth … Continued
(March 26, 2019) The NCCN, or the National Comprehensive Cancer Network, recently updated its clinical guidelines for the treatment of ovarian cancers. The guidelines, a summary of which can be found here, have been updated after several studies were completed and the FDA approved several new drugs. The new guidelines address topics such as PARP … Continued
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway inhibitor, such as PI3K, in order to increase the efficacy of PARP inhibitors in breast and epithelial ovarian cancers. Phase 1 trials are used … Continued
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill. Together, this passionate group of survivors, caregivers and supporters used their collective voice to advocate for increased funding for ovarian cancer research and education. Learn more about our asks for Ovarian Cancer Research Program (OCRP) … Continued
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through. Deadline is March 25th! Tell Congress to Increase OCRP Funding The Ovarian Cancer Research Program (OCRP) is a cutting-edge program housed within the Department of Defense and despite a … Continued
(March 18, 2019) Before the most recent study on the usage of lymphadenectomy, published earlier this month in the New England Journal of Medicine, it was thought that surgically removing clinically negative lymph nodes had a positive effect on the patient’s health. Now, doctors are rethinking that approach. The LION, Lymphadenectomy in Ovarian Neoplasms, trial … Continued
Get email updates about research news, action alerts, and ways to join the fight.
